Pharmaceutical Process Validation: An International (Drugs and the Pharmaceutical Sciences)
0824708385
9780824708382
Description:
The third edition of this text contains additional chapters which cover troubleshooting procedures, validation in contract manufacturing and current harmonization trends.
Best prices to buy, sell, or rent ISBN 9780824708382
Related Books
- 1
- 2
- 3
- Pharmaceutical Process Validation, 3Rd Revised Edition (Drugs And The Pharmaceutical Sciences, Volume 129)Alfred H. Wachter Robert A. NashISBN-13:9781138367623
- Pharmaceutical Process Validation: An International, Revised and ExpandedRobert A. NashEdition:3Rev EdISBN-13:9780824748340
- Pharmaceutical Process Validation, Second Edition (Drugs and the Pharmaceutical Sciences)Edition:2nd Revised & enlargedISBN-13:9780824787776
- Pharmaceutical Process Validation, 3Rd Revised Edition (Drugs And The Pharmaceutical Sciences, Volume 129)Alfred H. Wachter Robert A. NashISBN-13:9781138367623
- Pharmaceutical Process Validation: An International, Revised and ExpandedRobert A. NashEdition:3Rev EdISBN-13:9780824748340
Frequently Asked Questions about Pharmaceutical Process Validation: An International (Drugs and the Pharmaceutical Sciences)
The price for the book starts from $53.67 on Amazon and is available from 16 sellers at the moment.
If you’re interested in selling back the Pharmaceutical Process Validation: An International (Drugs and the Pharmaceutical Sciences) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Pharmaceutical Process Validation: An International (Drugs and the Pharmaceutical Sciences) book, the best buyback offer comes from and is $ for the book in good condition.
The Pharmaceutical Process Validation: An International (Drugs and the Pharmaceutical Sciences) book is in very low demand now as the rank for the book is 4,096,048 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.